1. Rubin BP, Antonescu CR, Gannon FH et al, Protocol for the examination of specimens from patients with tumors of bone. Arch Pathol Lab Med 2010; 134: e1–e7.
2. Glasser DB, Lane JM, Huvos AG et al, Survival, prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience. Cancer 1992; 69: 698–708.
3. Juergens H, Kosloff C, Nirenberg A et al, Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor). Natl Cancer Inst Monogr 1981; 56: 221–226.
4. Rosenberg AE, Cleton-Jansen AM, de Pinieux G et al, Conventional osteosarcoma. In: Fletcher CDM, Bridge JA, Hogendoorn PC et al, (eds). WHO Classification of Tumours of Soft Tissue and Bone, 4th edn. International Agency for Research on Cancer (IARC): Lyon, 2013, pp 282–288.
5. Oliveira A, Okada K, Squire J. Telangiectatic osteosarcoma. In: Fletcher CDM, Bridge JA, Hogendoorn PC et al, (eds). WHO Classification of Tumours of Soft Tissue and Bone, 4th edn. International Agency for Reseach on Cancer (IARC): Lyon, 2013, pp 289–290.